These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7883356)

  • 1. Pulse therapy in scleroderma.
    Vatwani V; Palta SC; Verma N; Pathak PR; Singh RP
    Indian Pediatr; 1994 Aug; 31(8):993-5. PubMed ID: 7883356
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and dexamethasone cyclophosphamide pulse therapy.
    Pasricha JS
    Indian J Dermatol Venereol Leprol; 2009; 75(5):510-1; author reply 514. PubMed ID: 19736435
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasome-cyclophosphamide pulse therapy for systemic sclerosis.
    Gupta R
    Indian J Dermatol Venereol Leprol; 2009; 75(5):511; author reply 514. PubMed ID: 19736436
    [No Abstract]   [Full Text] [Related]  

  • 5. Brachial plexopathy associated with diffuse edematous scleroderma.
    Mouthon L; Halimi C; Dussaule Md JC; Cayre-Castel Md M; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):303-5. PubMed ID: 10922959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report.
    Gupta R; Gupta S; Khera V
    J Dermatolog Treat; 2009; 20(1):55-8. PubMed ID: 18618362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Mittal G; Udwadia Z; Joshi VR
    J Rheumatol; 2003 May; 30(5):1121-2; author reply 1122. PubMed ID: 12734923
    [No Abstract]   [Full Text] [Related]  

  • 10. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
    Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
    Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
    Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
    Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term clinical-dispensary treatment of patients with systemic scleroderma].
    Grinberg NB; Ivanova AV
    Ter Arkh; 1976; 48(6):115-9. PubMed ID: 973177
    [No Abstract]   [Full Text] [Related]  

  • 14. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
    Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
    Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral Achilles tendinitis with spontaneous rupture induced by levofloxacin in a patient with systemic sclerosis.
    de La Red G; Mejía JC; Cervera R; Lladó A; Mensa J; Font J
    Clin Rheumatol; 2003 Oct; 22(4-5):367-8. PubMed ID: 14579169
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease.
    Kowal-Bielecka O; Distler O; Kowal K; Siergiejko Z; Chwiećko J; Sulik A; Gay RE; Łukaszyk AB; Gay S; Sierakowski S
    Arthritis Rheum; 2003 Jun; 48(6):1639-46. PubMed ID: 12794832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse cyclophosphamide decreases sympathetic postganglionic activity, controls alveolitis, and normalizes vascular tone dysfunction (Raynaud's phenomenon) in a case of early systemic sclerosis.
    Casale R; Generini S; Luppi F; Pignone A; Matucci-Cerinic M
    Arthritis Rheum; 2004 Aug; 51(4):665-9. PubMed ID: 15334442
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis.
    Holmberg LA; Furst DE; McSweeney PA; Nash RA
    J Rheumatol; 2009 Aug; 36(8):1839. PubMed ID: 19671826
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide in scleroderma lung disease.
    Sullivan KM; McSweeney PA; Nash RA
    N Engl J Med; 2006 Sep; 355(11):1173-4; author reply 1174. PubMed ID: 16977701
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.
    Valentini G; Paone C; La Montagna G; Chiarolanza I; Menegozzo M; Colutta E; Ruocco L
    Scand J Rheumatol; 2006; 35(1):35-8. PubMed ID: 16467039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.